© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to September
first-in-class allosteric SHP2 phosphatase inh.
oral agent in multiple trials for cancer
from 1.5M cmpd biochemical HTS + SBDD
J. Med. Chem., Sep. 24, 2020
Novartis, Cambridge, MA
TNO155 is an allosteric inhibitor of the SHP2 phosphatase, which has been a hot target in oncology recently due to its promotion of mutant KRAS activity as well as its…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.